2,903
Views
3
CrossRef citations to date
0
Altmetric
Coronavirus

COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study

, , , , , , , , ORCID Icon & ORCID Icon show all
Article: 2151798 | Received 27 Aug 2022, Accepted 22 Nov 2022, Published online: 02 Mar 2023

References

  • Yang X, Sun J, Patel RC, Zhang J, Guo S, Zheng Q, Olex AL, Olatosi B, Weissman SB, Islam JY, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8(11):e690–9. doi:10.1016/S2352-3018(21)00239-3.
  • Garbuglia AR, Minosse C, Del Porto P. mRNA- and adenovirus-based vaccines against SARS-CoV-2 in HIV-Positive people. Viruses. 2022;14(4):748. doi:10.3390/v14040748.
  • Coronavirus disease (COVID-19): COVID-19 vaccines and people living with HIV. [ accessed 2021 Jul 14]. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-covid-19-vaccines-and-people-living-with-hiv.
  • Trogen B, Oshinsky D, Caplan A. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA. 2020;323(24):2460–61. doi:10.1001/jama.2020.8917.
  • Harrison N, Poeppl W, Herkner H, Tillhof KD, Grabmeier-Pfistershammer K, Rieger A, Forstner C, Burgmann H, Lagler H. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18(7):500–06. doi:10.1111/hiv.12483.
  • Technical guideline for the inoculation of COVID-19 vaccines. [ accessed 2021 Apr 1]. http://en.nhc.gov.cn/2021-04/01/c_83365.htm.
  • Trovato M, Sartorius R, D’Apice L, Manco R, De Berardinis P. Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol. 2020;11:2130. doi:10.3389/fimmu.2020.02130.
  • Hoffmann C, Casado JL, Härter G, Vizcarra P, Moreno A, Cattaneo D, Meraviglia P, Spinner CD, Schabaz F, Grunwald S, et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021;22(5):372–78. doi:10.1111/hiv.13037.
  • Safety of COVID-19 vaccines. [ accessed 2021 Mar 31]. https://www.who.int/news-room/feature-stories/detail/safety-of-covid-19-vaccines.
  • Levy I, Wieder-Finesod A, Litchevsky V, Biber A, Indenbaum V, Olmer L, Huppert A, Mor O, Goldstein M, Levin EG, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021;27(12):1851–55. doi:10.1016/j.cmi.2021.07.031.
  • Frater J, Ewer KJ, Ogbe A, Pace M, Adele S, Adland E, Alagaratnam J, Aley PK, Ali M, Ansari MA, et al. Safety and immunogenicity of the ChAdox1 nCov-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021;8(8):E474–85. doi:10.1016/S2352-3018(21)00103-X.
  • Tuan JJ, Zapata H, Critch‐gilfillan T, Ryall L, Turcotte B, Mutic S, Andrews L, Roh ME, Friedland G, Barakat L, et al. Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV. HIV Med. 2022;23(2):178–85. doi:10.1111/hiv.13188.
  • Vallee A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 vaccine hesitancy among French people living with HIV. Vaccines (Basel). 2021;9(4):302. doi:10.3390/vaccines9040302.
  • Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis. Z Gesundh Wiss. 2022;1–25. doi:10.1007/s10389-021-01677-w.
  • Zhao HP, Wang H, Li H, Zheng W, Yuan T, Feng A, Luo D, Hu Y, Sun Y, Lin Y-F, et al. Uptake and adverse reactions of COVID-19 vaccination among people living with HIV in China: a case–control study. Hum Vaccines Immunother. 2021;17(12):4964–70. doi:10.1080/21645515.2021.1991183.
  • Transcript of the Press Conference of the Joint Prevention and Control Mechanism of The State Council on November 30, 2021. [ accessed 2021 Nov 30]. http://www.gov.cn/xinwen/gwylflkjz174/index.htm.
  • Tao L, Wang R, Han N, Liu J, Yuan C, Deng L, Han C, Sun F, Liu M, Liu J. Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. Hum Vaccin Immunother. 2021;17(8):2378–88. doi:10.1080/21645515.2021.1892432.
  • Qin C, Wang R, Tao L, Liu M, Liu J. Acceptance of a third dose of COVID-19 vaccine and associated factors in China based on health belief model: a national cross-sectional study. Vaccines (Basel). 2022;10(1):89. doi:10.3390/vaccines10010089.
  • Du M, Tao L, Liu J. The association between risk perception and COVID-19 vaccine hesitancy for children among reproductive women in China: an online survey. Front Med (Lausanne). 2021;8:741298. doi:10.3389/fmed.2021.741298.
  • Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–37. doi:10.1016/j.jpsychores.2005.10.020.
  • Teunissen JS, van der Oest MJW, van Groeninghen DE, Feitz R, Hovius SER, Van der Heijden EPA. The impact of psychosocial variables on initial presentation and surgical outcome for ulnar-sided wrist pathology: a cohort study with 1-year follow-up. BMC Musculoskelet Disord. 2022;23(1):109. doi:10.1186/s12891-022-05045-x.
  • Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593–602. doi:10.1038/s41586-022-04980-y.
  • Tao L, Wang R, Liu J. Comparison of vaccine acceptance between COVID-19 and seasonal influenza among women in China: a national online survey based on health belief model. Front Med (Lausanne). 2021;8:679520. doi:10.3389/fmed.2021.679520.
  • Liu Y, Han J, Li X, Chen D, Zhao X, Qiu Y, Zhang L, Xiao J, Li B, Zhao H. COVID-19 vaccination in people living with HIV (PLWH) in China: a cross sectional study of vaccine hesitancy, safety, and immunogenicity. Vaccines (Basel). 2021;9(12):1458. doi:10.3390/vaccines9121458.
  • Zheng W, Sun Y, Li H, Zhao H, Zhan Y, Gao Y, Hu Y, Li P, Lin Y-F, Chen H. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey. Hum Vaccin Immunother. 2021;17(12):4971–81. doi:10.1080/21645515.2021.1996152.
  • Nusair MB, Arabyat R, Khasawneh R, Al-Azzam S, Nusir AT, Alhayek MY. Assessment of the relationship between COVID-19 risk perception and vaccine acceptance: a cross-sectional study in Jordan. Hum Vaccin Immunother. 2022;18(1):2017734. doi:10.1080/21645515.2021.2017734.
  • Jaiswal J, Krause KD, Martino RJ, D’Avanzo PA, Griffin M, Stults CB, Karr AG, Halkitis PN. SARS-CoV-2 vaccination hesitancy and behaviors in a national sample of people living with HIV. AIDS Patient Care STDS. 2022;36(1):34–44. doi:10.1089/apc.2021.0144.
  • Ekstrand ML, Heylen E, Gandhi M, Steward WT, Pereira M, Srinivasan K. COVID-19 vaccine hesitancy among PLWH in South India: implications for vaccination campaigns. J Acquir Immune Defic Syndr. 2021;88(5):421–25. doi:10.1097/QAI.0000000000002803.
  • Menza TW, Capizzi J, Zlot AI, Barber M, Bush L. COVID-19 vaccine uptake among people living with HIV. AIDS Behav. 2022;26(7):2224–28. doi:10.1007/s10461-021-03570-9.
  • Prestage G, Storer D, Jin F, Haire B, Maher L, Philpot S, Bavinton B, Saxton P, Murphy D, Holt M. COVID-19 vaccine uptake and its impacts in a cohort of gay and bisexual men in Australia. AIDS Behav. 2022;26(8):2692–702. doi:10.1007/s10461-022-03611-x.
  • Sekizawa Y, Hashimoto S, Denda K, Ochi S, So M. Association between COVID-19 vaccine hesitancy and generalized trust, depression, generalized anxiety, and fear of COVID-19. BMC Public Health. 2022;22(1):126. doi:10.1186/s12889-021-12479-w.
  • Li Q, Lu HZ. Latest updates on COVID-19 vaccines. Biosci Trends. 2020;14(6):463–66. doi:10.5582/bst.2020.03445.
  • Shereen MA, Bashir N, Khan MA, Kazmi A, Khan S, Zhen L, Wu J, et al. Covid-19 management: traditional Chinese medicine Vs. Western medicinal antiviral drugs, a review and meta-analysis. Fresenius Environ Bull. 2021;30(5):5537–49.
  • Guess A, Nagler J, Tucker J. Less than you think: prevalence and predictors of fake news dissemination on Facebook. Sci Adv. 2019;5(1):eaau4586. doi:10.1126/sciadv.aau4586.
  • Eronen J, Paakkari L, Portegijs E, Saajanaho M, Rantanen T. Assessment of health literacy among older Finns. Aging Clin Exp Res. 2019;31(4):549–56. doi:10.1007/s40520-018-1104-9.
  • Rasi P, Vuojärvi H, Rivinen S. Promoting media literacy among older people: a systematic review. Adult Educ Q. 2020;71:37–54. doi:10.1177/0741713620923755.
  • Coronavirus disease (COVID-19): Vaccines. [ accessed 2022 Mar 16]. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-vaccines.
  • Ford N, Meintjes G, Vitoria M, Greene G, Chiller T. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017;12(2):123–28. doi:10.1097/COH.0000000000000348.
  • Guidance for COVID-19 and People with HIV. [ accessed 2022 Feb 22]. https://clinicalinfo.hiv.gov/en/guidelines/guidance-covid-19-and-people-hiv/guidance-covid-19-and-people-hiv?view=full.
  • Milano E, Ricciardi A, Casciaro R, Pallara E, De Vita E, Bavaro DF, Larocca AMV, Stefanizzi P, Tafuri S, Saracino A. Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: a monocentric study in Bari, Italy. J Med Virol. 2022;94(5):2230–36. doi:10.1002/jmv.27629.
  • Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O’Brien KL, Smith PG. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924–44. doi:10.1016/S0140-6736(22)00152-0.
  • Na H. Research progress in the epidemiology of HIV/AIDS in China. China CDC Wkly. 2021;3(48):1022–30. doi:10.46234/ccdcw2021.249.